Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex32-2.htm |
EX-32.1 - EXHIBIT 32.1 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex32-1.htm |
EX-31.2 - EXHIBIT 31.2 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex31-2.htm |
EX-31.1 - EXHIBIT 31.1 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex31-1.htm |
EX-23.1 - EXHIBIT 23.1 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex23-1.htm |
EX-10.23 - EXHIBIT 10.23 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex10-23.htm |
EX-10.22 - EXHIBIT 10.22 - EYEGATE PHARMACEUTICALS INC | tm211090d1_ex10-22.htm |
10-K - FORM 10-K - EYEGATE PHARMACEUTICALS INC | tm211090d1_10k.htm |
Exhibit 21.1
Subsidiaries of the Registrant
Jade Therapeutics, Inc. | (United States - Delaware) |
Panoptes Pharma Ges.m.b.H. | (Austria) |